The latest financial results for the current quarter have been declared, with a total of 1608 stocks announcing their performance for the period of December 2023. The trend over the last four quarters has shown a positive growth, with 52.0% of companies reporting positive results for the current quarter, followed by 50.0% in September 2023, 47.0% in June 2023, and 48.0% in March 2023.

In terms of market capitalization, large cap companies have shown the highest proportion of positive results at 62.0%, followed by mid cap at 53.0% and small cap at 44.0%. Among the top performers in each category, Punjab National Bank in the public banks sector has emerged as the top result for large cap companies, while Swan Energy in the textile sector has shown outstanding performance for mid cap companies. For small cap companies, Asian Energy in the oil exploration/refineries sector has reported the highest results.

In the last 24 hours, a total of 299 results have been declared, with Lupin emerging as the top performer. This pharmaceutical company has seen a bullish trend since January 2, 2024, with its score increasing from mildly bullish to bullish. The company's financial performance for the quarter of December 2023 has been outstanding, with a score of 37, a slight decrease from 39 in the last three months.

Lupin's financials for the quarter have shown significant growth, with its PAT (profit after tax) growing at 84.2%, the highest among all companies. Its net sales have also reached a record high of Rs 5,197.41 crore, while its operating profit to interest ratio is at 14.02 times, the highest in the industry. The company's PBDIT (profit before depreciation, interest, and taxes) has also reached its highest at Rs 1,037.94 crore, and its operating profit to net sales ratio is at 19.97%. Additionally, its PBT (profit before tax) less OI (other income) has grown at 79.5%, with a total of Rs 706.73 crore, the highest among all companies. Lupin's EPS (earnings per share) for the quarter is also at its highest at Rs 13.46, while its debt-equity ratio is the lowest at 0.29 times and its debtors turnover ratio is the highest at 4.09 times.

Investors can look forward to upcoming results from Zydus Lifesciences, Hero MotoCorp, and Emami on February 9, 2024. With Lupin's outstanding financial performance and other top performers in the current quarter, the market is expected to see positive growth in the coming months.